Notices. Notice Announcing Technical Assistance Workshops for fiscal year (FY) 2007 Developing Hispanic-Serving Institutions (HSI) program

13,929 words·~63 min read·/register/2006/12/26/06-9843

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 3710-CE-M DEPARTMENT OF EDUCATION [CFDA No: 84.031S] Office of Postsecondary Education, Institutional Development and Undergraduate Educational Services ACTION: Notice Announcing Technical Assistance Workshops for fiscal year

(FY)2007 Developing Hispanic-Serving Institutions

(HSI)program. SUMMARY: This notice provides information about seven one-day technical assistance workshops to assist institutions of higher education interested in preparing grant applications for FY 2007 new awards under the HSI program. Staff will present information about the purpose of the HSI program, selection criteria, application content, submission procedures, and reporting requirements. Although the Department has not yet announced an application deadline date in the **Federal Register** for the FY 2007 competition, the Department is holding these workshops to give potential applicants guidance for preparing applications for the competition we expect to conduct in FY 2007. Specific requirements for the FY 2007 competition will be published in a separate **Federal Register** notice. This notice announces the technical assistance workshops only. FOR FURTHER INFORMATION CONTACT: Josephine Hamilton, Team Leader or Carlin Hertz, Developing Hispanic- Serving Institutions

(HSI)program, U.S. Department of Education, 1990 K Street, NW., room 6052, Washington, DC 20006-8513. Telephone:

(202)502-7777. If you use a telecommunications device for the deaf (TDD), you may call the Federal Relay Service

(FRS)at 1-800-877-8339. Individuals with disabilities may obtain this document in an alternative format ( *e.g.* , Braille, large print, audio tape, or computer diskette) on request to the contact person listed in this section. Registration information and the registration form for the technical assistance workshops will be posted on the Internet at the following site: *http://www.ed.gov/programs/idueshsi/index.html.* SUPPLEMENTARY INFORMATION: The technical assistance workshops will be held as follows: 1. Washington, DC: Wednesday, January 10, 2007. U.S. Department of Education, 400 Maryland Avenue, SW., Barnard Auditorium, Washington, DC 20202. 2. Santurce, Puerto Rico: Wednesday, January 17, 2007. Sacred Heart University, Avenida Eduardo Conde, Library Conference Room, Santurce, Puerto Rico 00909. 3. Cayey, Puerto Rico: Thursday, January 18, 2007. University of Puerto Rico, Avenida Barcelo, Cayey, Puerto Rico 00736. 4. Norwalk, California: Monday, January 22, 2007. Cerritos College, 11110 Alandra Boulevard, Learning Resource Center, Room LCC 155, Norwalk, California 90650. 5. Santa Fe, New Mexico: Wednesday, January 24, 2007. Santa Fe Community College, 6401 Richards Avenue, Administration Building: Jemez Room, Santa Fe, New Mexico 87508. 6. San Antonio, Texas: Monday, January 29, 2007. University of Texas at San Antonio, One UTSA Circle, Business Building, University Room BB 2.06.04, San Antonio, Texas 78249. 7. El Paso, Texas: Wednesday, January 31, 2007. El Paso Community College, 9050 Viscount Boulevard, Administration Services Center, El Paso, Texas 79927. All Technical Assistance Workshop sessions will be conducted from 8 a.m.-5 p.m. each day. Please contact the Department of Education contact persons listed under FOR FURTHER INFORMATION CONTACT if you have any questions about the details of the workshops. You will need to pre-register at our Web site listed under FOR FURTHER INFORMATION CONTACT ; however, there is no registration fee. We encourage attendance from those who will be responsible for submitting the application electronically using the Grants.gov Apply site. Assistance to Individuals With Disabilities Attending the Technical Assistance Workshop The technical assistance workshop sites are accessible to individuals with disabilities. If you need an auxiliary aid or service to participate in a workshop ( *e.g.* , interpreting service, assistive listening device, or materials in an alternative format), notify the person(s) listed under FOR FURTHER INFORMATON CONTACT at least two weeks before the scheduled workshop date. Although we will attempt to meet a request received after that date, we may not be able to make the requested auxiliary aid or service available because of insufficient time to arrange it. Electronic Access to This Document You may view this document, as well as other documents of this Department published in the **Federal Register** , in text or Adobe Portable Document Format

(PDF)on the Internet at the following site: *http://www.ed.gov/news/fedregister.* To use PDF, you must have Adobe Acrobat Reader, which is available free at this site. If you have any questions about using the PDF, call the U.S. Government Printing Office (GPO), toll free, at 1-888-293-6498; or in the Washington, DC area at

(202)512-1530. Note: The official version of this document is the document published in the **Federal Register** . Free Internet access to the official edition of the **Federal Register** and the Code of Federal Regulations is available on GPO Access at: *http://www.gpoaccess.gov/nara/index.html.* *Program Authority:* 20 U.S.C. 1101. Dated: December 20, 2006. James F. Manning, Delegated the Authority of Assistant Secretary for Postsecondary Education. [FR Doc. E6-22075 Filed 12-22-06; 8:45 am] BILLING CODE 4000-01-P DEPARTMENT OF ENERGY Environmental Management Site-Specific Advisory Board, Nevada AGENCY: Department of Energy. ACTION: Notice of open meeting. SUMMARY: This notice announces a meeting of the Environmental Management Site-Specific Advisory Board (EM SSAB), Nevada Test Site. The Federal Advisory Committee Act (Pub. L. 92-463, 86 Stat. 770) requires that public notice of this meeting be announced in the **Federal Register** . DATES: Wednesday, January 10, 2007, 5 p.m. ADDRESSES: 7710 West Cheyenne Avenue, Conference Room # 130, Las Vegas, Nevada. FOR FURTHER INFORMATION CONTACT: Kelly Snyder, Deputy Designated Federal Officer, P.O. Box 98518, Las Vegas, Nevada 89193. Phone:

(702)295-2836; E-mail: *snyderk@nv.doe.gov.* SUPPLEMENTARY INFORMATION: *Purpose of the Board:* The purpose of the Board is to make recommendations to DOE in the areas of environmental restoration, waste management, and related activities. *Tentative Agenda:* Committee updates and discussion of future meeting topics. *Public Participation:* The meeting is open to the public. Written statements may be filed with the Board either before or after the meeting. Individuals who wish to make oral presentations pertaining to agenda items should contact Kelly Snyder at the telephone number listed above. The request must be received five days prior to the meeting and reasonable provision will be made to include the presentation in the agenda. The Deputy Designated Federal Officer is empowered to conduct the meeting in a fashion that will facilitate the orderly conduct of business. Individuals wishing to make public comment will be provided a maximum of five minutes to present their comments. This notice is being published less than 15 days prior to the meeting date due to programmatic issues that had to be resolved prior to the meeting date. *Minutes:* The minutes of this meeting will be available for public review and copying at the U.S. Department of Energy's Freedom of Information Public Reading Room, 1E-190, Forrestal Building, 1000 Independence Avenue, SW., Washington, DC 20585 between 9 a.m. and 4 p.m., Monday through Friday, except Federal holidays. Minutes will also be available by writing to Kelly Snyder at the address listed above. Issued at Washington, DC, on December 20, 2006. Rachel Samuel, Deputy Advisory Committee Management Officer. [FR Doc. E6-22046 Filed 12-22-06; 8:45 am] BILLING CODE 6450-01-P DEPARTMENT OF ENERGY Office of Energy Efficiency and Renewable Energy State Energy Advisory Board AGENCY: Department of Energy. ACTION: Notice of open teleconference. SUMMARY: This notice announces a teleconference of the State Energy Advisory Board (STEAB). The Federal Advisory Committee Act (Pub. L. 92-463; 86 Stat. 770) requires that public notice of these teleconferences be announced in the **Federal Register** . DATES: January 18, 2007, from 2 p.m. to 3 p.m. EST. FOR FURTHER INFORMATION CONTACT: Gary Burch, STEAB Designated Federal Officer, Assistant Manager, Intergovernmental Projects & Outreach, Golden Field Office, U.S. Department of Energy, 1617 Cole Boulevard, Golden, CO 80401, Telephone 303/275-4801. SUPPLEMENTARY INFORMATION: *Purpose of the Board* : To make recommendations to the Assistant Secretary for Energy Efficiency and Renewable Energy regarding goals and objectives, programmatic and administrative policies, and to otherwise carry out the Board's responsibilities as designated in the State Energy Efficiency Programs Improvement Act of 1990 (Pub. L. 101-440). *Tentative Agenda:* Update members on routine business matters. *Public Participation:* The teleconference is open to the public. Written statements may be filed with the Board either before or after the meeting. Members of the public who wish to make oral statements pertaining to agenda items should contact Gary Burch at the address or telephone number listed above. Requests to make oral comments must be received five days prior to the conference call; reasonable provision will be made to include requested topic(s) on the agenda. The Chair of the Board is empowered to conduct the call in a fashion that will facilitate the orderly conduct of business. Notes: The notes of the teleconference will be available for public review and copying within 60 days at the Freedom of Information Public Reading Room, 1E-190, Forrestal Building, 1000 Independence Avenue, SW., Washington, DC, between 9 a.m. and 4 p.m., Monday through Friday, except Federal holidays. The notes will also be made available for downloading on the STEAB Web site, *http://www.steab.org,* within 60 days. Issued at Washington, DC, on December 20, 2006. Rachel Samuel, Deputy Advisory Committee Management Officer. [FR Doc. E6-22047 Filed 12-22-06; 8:45 am] BILLING CODE 6450-01-P ENVIRONMENTAL PROTECTION AGENCY [FRL-8260-8] Notice of Public Meeting on EPA Geospatial Data Access Project AGENCY: Environmental Protection Agency. ACTION: Notice of public meeting. SUMMARY: Environmental Protection Agency

(EPA)will hold a public meeting to solicit comments and feedback on the Agency's project to share and publish information on locations of environmental interest through commercial Internet services. This project is designed to increase the awareness and availability of environmental information to the public. The project includes a pilot to publish environmental data from the Superfund program (National Priorities List) with the project then being expanded to other U.S. EPA data resources. DATES: The meeting will take place on Wednesday, January 17, 2007 from 1 p.m. to 3:30 p.m. (EST). ADDRESSES: The meeting will be held at EPA's Offices at 1 Potomac Yard, First Floor Conference Center, 2777 Crystal Drive, Arlington, VA 22202. FOR FURTHER INFORMATION CONTACT: Dalroy Ward (Mail Stop 2843T), Environmental Protection Agency, 1200 Pennsylvania Avenue, NW., Washington, DC 20460; telephone

(202)566-0381, e-mail: *ward.dalroy@epa.gov.* SUPPLEMENTARY INFORMATION: EPA is initiating a project to foster collaboration with commercial publishers of geospatial data content to improve accessibility and increase public awareness of EPA's environmental data holdings. First steps consist of publishing environmental data from the Superfund program in XML format and made available to any interested parties. The data available through the project will be expanded after its initial release and may include data from other EPA programs. EPA's goal is to establish a single venue for providing and maintaining access to its environmental content that can be utilized by any commercial service provider with an interest in doing so. Background This meeting is informational and is an opportunity for EPA to present the methodology it will be following in making the data available and provide an opportunity for interested parties to ask questions to aid in their understanding. Agenda 1 Welcome and EPA Introductions 1:15 Presentation on EPA's Geospatial Data Access Project 2 Presentation on the XML Schema and Tag Definitions 2:30 Questions and Answers During the presentation attendees will have the opportunity to submit written questions. EPA will answer all questions that can be answered that are germane to the meeting and for which there is time available in the schedule. Some questions may require additional materials to be prepared and such questions will be deferred until after the meeting. Relevant questions not answered at the meeting will be answered in writing with the answers made available on the Geospatial Data Access Project Web site. How can I participate in the meeting? This meeting will be open to the public and seating is available on a first-come basis. Persons interested in attending do not need to register in advance of the meeting. To request accommodation of a disability, please contact the person listed under FOR FURTHER INFORMATION CONTACT , preferably at least 10 days prior to the meeting, to give EPA as much time as possible to process your request. Dated: December 11, 2006. Linda A. Travers, Acting Assistant Administrator and Chief Information, Officer, Office of Environmental Information. [FR Doc. E6-22050 Filed 12-22-06; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-ORD-2006-0798; FRL-8261-1] Human Studies Review Board (HSRB); Notification of a Public Teleconference to Review Its Draft Report From the October 18-19, 2006 HSRB Meeting AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: The EPA Human Studies Review Board

(HSRB)announces a public teleconference meeting to discuss its draft HSRB report from the October 18-19, 2006 HSRB meeting. DATES: The teleconference will be held on January 18, 2007, from 1:30 to approximately 4 p.m. (Eastern Time). *Location:* The meeting will take place via telephone only. *Meeting Access:* For information on access or services for individuals with disabilities, please contact the person listed under FOR FURTHER INFORMATION CONTACT , so that appropriate arrangements can be made. *Procedures for Providing Public Input:* Interested members of the public may submit relevant written or oral comments for the HSRB to consider during the advisory process. Additional information concerning submission of relevant written or oral comments is provided in Unit I.D. of this notice. FOR FURTHER INFORMATION CONTACT: Members of the public who wish to obtain the call-in number and access code to participate in the telephone conference, request a current draft copy of the Board's report or who wish further information may contact Lu-Ann Kleibacker, EPA, Office of the Science Advisor, (8105R), Environmental Protection Agency, 1200 Pennsylvania Avenue, NW., Washington, DC 20460; telephone

(202)564-7189 or via e-mail at *kleibacker.lu-ann@epa.gov* . General information concerning the EPA HSRB can be found on the EPA Web site at *http://www.epa.gov/osa/hsrb/* . ADDRESSES: Submit your written comments, identified by Docket ID No. EPA-HQ-ORD-2006-0798, by one of the following methods: *http://www.regulations.gov:* Follow the on-line instructions for submitting comments. *E-mail:* *ORD.Docket@epa.gov* . *Mail:* ORD Docket, Environmental Protection Agency, Mailcode: 28221T, 1200 Pennsylvania Ave., NW., Washington, DC 20460. *Hand Delivery:* EPA Docket Center (EPA/DC), Public Reading Room, Infoterra Room (Room Number 3334), EPA West Building, 1301 Constitution Avenue, NW., Washington, DC 20460, Attention Docket ID No. EPA-ORD-2006-0798. Deliveries are only accepted from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. Special arrangements should be made for deliveries of boxed information. *Instructions:* Direct your comments to Docket ID No. EPA-HQ-ORD-2006-0798. EPA's policy is that all comments received will be included in the public docket without change and may be made available online at *http://www.regulations.gov* , including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through *http://www.regulations.gov* or e-mail. The *http://www.regulations.gov* Web site is an “anonymous access” system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA, without going through *http://www.regulations.gov* , your e-mail address will be automatically captured and included as part of the comment that is placed in the public docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD-ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. I. Public Meeting A. Does This Action Apply to Me? This action is directed to the public in general. This action may, however, be of interest to persons who conduct or assess human studies, including such studies on substances regulated by EPA, or to persons who are or may be required to conduct testing of chemical substances under the Federal Food, Drug, and Cosmetic Act (FFDCA) or the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT. B. How Can I Access Electronic Copies of This Document and Other Related Information? In addition to using regulations.gov, you may access this **Federal Register** document electronically through the EPA Internet under the “Federal Register” listings at *http://www.epa.gov/fedrgstr/* . *Docket:* All documents in the docket are listed in the *http://www.regulations.gov* index. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, will be publicly available only in hard copy. Publicly available docket materials are available either electronically in *http://www.regulations.gov* or in hard copy at the ORD Docket, EPA/DC, Public Reading Room, Infoterra Room (Room Number 3334), EPA West Building, 1301 Constitution Ave., NW., Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is

(202)566-1744, and the telephone number for the ORD Docket is

(202)566-1752. The October 18-19, 2006 HSRB meeting draft report is now available. You may obtain electronic copies of this document, and certain other related documents that might be available electronically, from the regulations.gov Web site and the HSRB Internet Home Page at *http://www.epa.gov/osa/hsrb/* . For questions on document availability or if you do not have access to the Internet, consult the person listed under FOR FURTHER INFORMATION CONTACT . C. What Should I Consider as I Prepare My Comments for EPA? You may find the following suggestions helpful for preparing your comments: 1. Explain your views as clearly as possible. 2. Describe any assumptions that you used. 3. Provide copies of any technical information and/or data you used that support your views. 4. Provide specific examples to illustrate your concerns and suggest alternatives. 5. To ensure proper receipt by EPA, be sure to identify the docket ID number assigned to this action in the subject line on the first page of your response. You may also provide the name, date, and **Federal Register** citation. D. How May I Participate in This Meeting? You may participate in this meeting by following the instructions in this section. To ensure proper receipt by EPA, it is imperative that you identify docket ID number EPA-HQ-ORD-2006-0798 in the subject line on the first page of your request. 1. *Oral comments* . Requests to present oral comments will be accepted up to January 11, 2007. To the extent that time permits, interested persons who have not pre-registered may be permitted by the Chair of the HSRB to present oral comments at the meeting. Each individual or group wishing to make brief oral comments to the HSRB is strongly advised to submit their request (preferably via e-mail) to the person listed under FOR FURTHER INFORMATION CONTACT no later than noon, Eastern Time, January 11, 2007, in order to be included on the meeting agenda and to provide sufficient time for the HSRB Chair and HSRB Designated Federal Official to review the meeting agenda to provide an appropriate public comment period. The request should identify the name of the individual making the presentation and the organization (if any) the individual will represent. Oral comments before the HSRB are limited to five minutes per individual or organization. Please note that this includes all individuals appearing either as part of, or on behalf of an organization. While it is our intent to hear a full range of oral comments on the science and ethics issues under discussion, it is not our intent to permit organizations to expand these time limitations by having numerous individuals sign up separately to speak on their behalf. If additional time is available, there may be flexibility in time for public comments. 2. *Written comments* . Although you may submit written comments at any time, for the HSRB to have the best opportunity to review and consider your comments as it deliberates on its report, you should submit your comments at least five business days prior to the beginning of this teleconference. If you submit comments after this date, those comments will be provided to the Board members, but you should recognize that the Board members may not have adequate time to consider those comments prior to making a decision. Thus, if you plan to submit written comments, the Agency strongly encourages you to submit such comments no later than noon, Eastern Time, January 11, 2007. You should submit your comments using the instructions in Unit 1.C. of this notice. In addition, the Agency also requests that person(s) submitting comments directly to the docket also provide a copy of their comments to the person listed under FOR FURTHER INFORMATION CONTACT . There is no limit on the length of written comments for consideration by the HSRB. E. Background The EPA Human Studies Review Board will be reviewing its draft report from the October 18-19, 2006 HSRB meeting. Background on the October 18-19, 2006 HSRB meeting can be found at **Federal Register** 71 187, 56527 (September 27, 2006) and at the HSRB Web site *http://www.epa.gov/osa/hsrb/* . Finally, the Board may discuss planning for future HSRB meetings. Dated: December 19, 2006. George M. Gray, EPA Science Advisor. [FR Doc. E6-22052 Filed 12-22-06; 8:45 am] BILLING CODE 6560-50-P FEDERAL DEPOSIT INSURANCE CORPORATION Agency Information Collection Activities: Submission for OMB Review; Comment Request AGENCY: Federal Deposit Insurance Corporation (FDIC). ACTION: Notice of information collections to be submitted to OMB for review and approval under the Paperwork Reduction Act of 1995. SUMMARY: In accordance with requirements of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 *et seq.* ), the FDIC hereby gives notice that it plans to submit to the Office of Management and Budget

(OMB)a request for OMB review and approval of the information collection system described below. DATES: Comments must be submitted on or before January 25, 2007. ADDRESSES: Interested parties are invited to submit written comments to Steve Hanft, Paperwork Clearance Officer,

(202)898-3907, Legal Division, Federal Deposit Insurance Corporation, 550 17th Street, NW., Washington, DC 20429. All comments should refer to the OMB control number. Comments may be hand-delivered to the guard station at the rear of the 17th Street Building (located on F Street), on business days between 7 a.m. and 5 p.m. [FAX number

(202)898-8788]. A copy of the comments may also be submitted to: OMB desk officer for the FDIC, Office of Information and Regulatory Affairs, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503. FOR FURTHER INFORMATION CONTACT: Steve Hanft, at the address identified above. SUPPLEMENTARY INFORMATION: Proposal to renew the following currently approved collection of information: *Title:* Foreign Banks. *OMB Number:* 3064-0114. *Frequency of Response:* On occasion. *Affected Public:* Certain U.S. branches of foreign banks. *Estimated Number of Respondents:* 12. *Estimated Time per Response:* 131. *Total Annual Burden:* 1,572 hours. *General Description of Collection:* This collection consists of applications relating to the FDIC's supervision of insured branches of foreign banks. The applications cover such actions as moving a branch, operating as a noninsured state-licensed branch of a foreign bank, conducting activities which are not permissible for a federally-licensed branch internal recordkeeping; and reporting and recordkeeping requirements relating to pledges of assets to the FDIC. Request for Comment Comments are invited on:

(a)Whether this collection of information is necessary for the proper performance of the FDIC's functions, including whether the information has practical utility;

(b)the accuracy of the estimate of the burden of the information collection, including the validity of the methodology and assumptions used;

(c)ways to enhance the quality, utility, and clarity of the information to be collected; and

(202)898-3907, Legal Division, Federal Deposit Insurance Corporation, 550 17th Street NW., Washington, DC 20429. All comments should refer to the OMB control number. Comments may be hand-delivered to the guard station at the rear of the 17th Street Building (located on F Street), on business days between 7 a.m. and 5 p.m. [FAX number

(202)898-8788]. A copy of the comments may also be submitted to: OMB desk officer for the FDIC, Office of Information and Regulatory Affairs, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503. FOR FURTHER INFORMATION CONTACT: Steve Hanft, at the address identified above. SUPPLEMENTARY INFORMATION: Proposal to renew the following currently approved collection of information: 1. *Title:* Occasional Qualitative Surveys. *OMB Number:* 3064-0127. *Frequency of Response:* On occasion. *Affected Public:* Financial institutions, their customers, and members of the public generally. *Estimated Number of Respondents:* 12,750. *Estimated Time per Response:* 1 hour. *Total Annual Burden:* 12,750 hours. *General Description of Collection:* This collection involves the occasional use of qualitative surveys to gather anecdotal information about regulatory burden, bank customer satisfaction, problems or successes in the bank supervisory process (both safety-and-soundness and consumer related), and similar concerns. In general, these surveys would not involve more than 850 respondents, would not require more than one hour per respondent, and would be completely voluntary. It is not contemplated that more than fifteen such surveys would be completed in any given year. Request for Comment Comments are invited on:

(a)Whether this collections of information is necessary for the proper performance of the FDIC's functions, including whether the information has practical utility;

(b)the accuracy of the estimate of the burden of the information collection, including the validity of the methodology and assumptions used;

(c)ways to enhance the quality, utility, and clarity of the information to be collected; and

(d)ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology. All comments will become a matter of public record. Dated at Washington, DC, this 19th day of December, 2006. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. E6-22066 Filed 12-22-06; 8:45 am] BILLING CODE 6714-01-P FEDERAL DEPOSIT INSURANCE CORPORATION Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Federal Deposit Insurance Corporation (FDIC). ACTION: Notice and request for comment. SUMMARY: The FDIC, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). Currently, the FDIC is soliciting comments concerning the following collections of information titled. DATES: Comments must be submitted on or before February 26, 2007. ADDRESSES: Interested parties are invited to submit written comments by any of the following methods. All comments should refer to the name and number of the collection: • *http://www.FDIC.gov/regulations/laws/federal/notices.html.* • *E-mail:* *comments@fdic.gov.* Include the name and number of the collection in the subject line of the message. • *Mail:* Steve Hanft (202-898-3907), Clearance Officer, Federal Deposit Insurance Corporation, 550 17th Street, NW., Washington, DC 20429. • *Hand Delivery:* Comments may be hand-delivered to the guard station at the rear of the 550 17th Street Building (located on F Street), on business days between 7 a.m. and 5 p.m. A copy of the comments may also be submitted to the OMB Desk Officer for the FDIC, Office of Information and Regulatory Affairs, Office of Management and Budget, New Executive Office Building, Washington, DC 20503. FOR FURTHER INFORMATION CONTACT: Steve Hanft, at the address identified above. SUPPLEMENTARY INFORMATION: Proposal to renew the following currently approved collections of information: 1. *Title:* Securities of Insured Nonmember Banks. *OMB Number:* 3064-0030. *Form Numbers:* 3, 4, 5. *Frequency of Response:* On occasion. *Affected Public:* Generally, any person subject to section 16 of the Securities Exchange Act of 1934 with respect to securities registered under 12 CFR part 335. *Estimated Number of Respondents:* 1,333. *Estimated Time per Response:* 0.6 hours. *Total Annual Burden:* 1,800 hours. *General Description of Collection:* FDIC bank officers, directors, and persons who beneficially own more than 10% of a specified class of registered equity securities are required to publicly report their transactions in equity securities of the issuer. 2. *Title:* Forms Relating to Outside Counsel, Legal Support and Expert Services Programs. *OMB Number:* 3064-0122. *Form Numbers:* 5000/24-29; 5000/31-35; 5200/01; 5210/01-15. *Frequency of Response:* On occasion. *Affected Public:* Those who wish to be or are providers of legal support services to the FDIC. *Estimated Number of Respondents:* 4,603. *Estimated Time per Response:* 0.8 hours. *Total Annual Burden:* 3,711 hours. *General Description of Collection:* These forms facilitate the procurement of and payment for legal services; ensure compliance with statutory and regulatory requirements relating to disqualifying conditions or conflicts of interest; and monitor the participation of women and minorities in legal services contracts. Request for Comment Comments are invited on:

(a)Whether the collection of information is necessary for the proper performance of the FDIC's functions, including whether the information has practical utility;

(b)the accuracy of the estimates of the burden of the information collection, including the validity of the methodology and assumptions used;

(c)ways to enhance the quality, utility, and clarity of the information to be collected; and

(d)ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology. At the end of the comment period, the comments and recommendations received will be analyzed to determine the extent to which the collection should be modified prior to submission to OMB for review and approval. Comments submitted in response to this notice also will be summarized or included in the FDIC's requests to OMB for renewal of these collections. All comments will become a matter of public record. Dated at Washington, DC, this 20th day of December, 2006. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. E6-22067 Filed 12-22-06; 8:45 am] BILLING CODE 6714-01-P FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than January 19, 2007. **A. Federal Reserve Bank of San Francisco** (Tracy Basinger, Director, Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105-1579: *1. City National Corporation* , Beverly Hills, California; to merge with Business Bank Corporation, and thereby indirectly acquire Business Bank of Nevada, both of Las Vegas, Nevada. Board of Governors of the Federal Reserve System, December 20, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6-22033 Filed 12-22-06; 8:45 am] BILLING CODE 6210-01-S GENERAL SERVICES ADMINISTRATION Privacy Act of 1974; Notice of updated System of Records AGENCY: General Services Administration ACTION: Notice of updated system of records SUMMARY: The General Services Administration

(GSA)is providing notice of an update to the record system Employee Drug Abuse/Alcoholism Files (GSA/HRO-2). The system includes counseling and rehabilitation referrals and records of counseling and rehabilitation. EFFECTIVE DATE: The system of records will become effective without further notice on January 25, 2007 unless comments received on or before that date result in a contrary determination. FOR FURTHER INFORMATION CONTACT: Call or e-mail the GSA Privacy Act Officer: telephone 202-501-1452/202-208-1317; *e-mail gsa.privacyact@gsa.gov/* ADDRESSES: Comments may be submitted to the Director, Human Capital Policy and Program Management Division (CHP), Office of Human Capital Management (CH), 1800 F Street NW, Washington, DC 20405. SUPPLEMENTARY INFORMATION: GSA reviewed this Privacy Act system of record to ensure that it is relevant, necessary, accurate, up-to-date, and covered by the appropriate legal or regulatory authority. Nothing in the updated system notice indicates a change in authorities or practices regarding the collection and maintenance of information. Nor do the changes impact individuals’ rights to access or amend their records in the system of records. Dated: December 18, 2006. Cheryl M. Paige Acting Director, Office of Information Management GSA/HRO-2 System name: Employee Drug Abuse/Alcoholism Files Location: The system is located in the office of the private sector organizations or providers for the Employee Assistance Program

(EAP)who have contracted with the *Office of Human Resources Services at GSA.* The EAP office contacts are as follows: Central Office Federal Occupational Health (800)222-0364 National Capital Region Federal Occupational Health (800)222-0364 Northeast and Caribbean Region Cooperative Administrative Support Program Consortia Long Island and Queens: (516)222-1221 New Jersey: (201)402-1015 Puerto Rico and the Virgin Islands: (809)763-6701 or (800)981-5070 New York City: (212)264-4673 New England: (617)565-6533 or (800)869-8867 Mid-Atlantic Region Federal Occupational Health (800)222-0364 Southeast Sunbelt Region Davine Sparks, LCSW (800)222-0364 or (404)730-3237 Great Lakes Region Federal Occupational Health (800)222-0364 The Heartland Region Federal Occupational Health

(800)222-0364 Greater Southwest Region Federal Occupational Health (800)222-0364 or (888)262-7848 Pacific Rim Region North of Bakersfield: Linda Boone or Jean Taylor (415)436-7448 South of Bakersfield: Joan Sexton (213)894-0160 or Sandy Freed (213)894-0153 New England Region (617)565-6533 or

(800)869-8867 Rocky Mountain Region Federal Occupational Health (800)222-0364 or (888)262-7848(TTY) Types of records in the system: 1. Counseling and rehabilitation referrals. 2. Records of counseling and rehabilitation. Authority for maintaining the system: Pub. L. 92-255 and 5 U.S.C. 7904. Purpose: To maintain an information system on employees suspected of abusing or known to abuse alcohol or another drug and for self-initiated referrals. Routine uses of the record system, including types of users and their purposes in using it: Disclosing information related to anyone with a history of alcohol or drug abuse is restricted by Alcohol and Drug Abuse Patient Records regulations, 42 CFR part 2. System information may be accessed and used by authorized Federal agency employees or contractors to conduct official duties. Information from this system also may be disclosed as a routine use: a. Documenting that the supervisor deals properly with an employee whose work is affected by alcohol abuse or other drug abuse. b. Communicating information to those who use it in performing their duties, such as a counselor, medical or health worker, an alcohol or other drug abuse program administrator, or a qualified service organization. c. Disclosing information to the Department of Justice or another Federal agency in defending a claim against the United States, when the claim is based on a person's mental or physical condition and is allegedly caused by GSA activities affecting the person. d. In any legal proceeding, where pertinent, to which GSA is a party before a court or administrative body. e. To authorized officials engaged in investigating or settling a grievance, complaint, or appeal filed by an individual who is the subject of the record. f. To a Federal agency in connection with the hiring or retention of an employee; the issuance of a security clearance; the reporting of an investigation; the letting of a contract; or the issuance of a grant, license, or other benefit to the extent that the information is relevant and necessary to a decision. g. To the Office of Personnel Management (OPM), the Office of Management and Budget (OMB), or the Government Accountability Office

(GAO)when the information is required for program evaluation purposes. h. To a Member of Congress or staff on behalf of and at the request of the individual who is the subject of the record. i. To an expert, consultant, or contractor of GSA in the performance of a Federal duty to which the information is relevant. j. To the National Archives and Records Administration

(NARA)for records management purposes. Policies and practices for storing, retrieving, accessing, retaining and disposing of records in the system: Storage: Paper records are kept in a file cabinet or in a drawer. Retrievability: The records are filed alphabetically by name. Safeguards: When not in use by an authorized person, the records are stored in a locked metal file cabinet or in a secured room. Retention and disposal: The records are kept for a year after the employee's last contact with a counselor or until the employee separates or transfers, whichever occurs first. If there is an EEO case, MSPB appeal, or arbitration, the records are kept for 3 years after the case is resolved. Records are destroyed by shredding or burning. System manager(s) and address: The Director, Human Capital Policy and Program Management Division (CHP), Office of Human Capital Management (CH), 1800 F Street NW, Washington, DC 20405. Notification procedure: An employee may obtain information as to whether he or she is part of the system of records from the immediate supervisor or the Director of Human Capital Policy and Program Management Division at the address above, whichever is appropriate. Record access procedure: A request to review a record related to you should be directed to the immediate supervisor or Director of Human Capital Policy and Program Management Division at the address above, whichever is appropriate. For the identification required, see 41 CFR part 105-64 published in the **Federal Register** . Procedure to contest a record: GSA rules to review the content of a record and appeal an initial decision are in 41 CFR part 105-64 published in the **Federal Register** . Record sources: The supervisor(s), counselors, personnel specialists, and individual employee. [FR Doc. E6-22003 Filed 12-22-06; 8:45 am] BILLING CODE 6820-34-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2006P-0085] Medical Devices; Exemptions from Premarket Notification; Class II Devices AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration

(FDA)is publishing an order denying a petition requesting exemption for cranial orthosis type devices from the premarket notification requirements for certain class II devices. A cranial orthosis device is a device intended to apply pressure to prominent regions of an infant's cranium in order to improve cranial symmetry or shape. FDA is publishing this notice in accordance with procedures established by the Food and Drug Administration Modernization Act of 1997 (FDAMA). DATES: This order is effective December 26, 2006. FOR FURTHER INFORMATION CONTACT: Heather Rosecrans, Center for Devices and Radiological Health (HFZ-404), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240-276-4040. SUPPLEMENTARY INFORMATION: I. Background Under section 513 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360c), FDA must classify devices into one of three regulatory classes: class I, class II, or class III. FDA classification of a device is determined by the amount of regulation necessary to provide a reasonable assurance of safety and effectiveness. Under the Medical Device Amendments of 1976 (the 1976 amendments (Public Law 94-295)), as amended by the Safe Medical Devices Act of 1990 (the SMDA) (Public Law 101-629)), devices are to be classified into class I (general controls) if there is information showing that the general controls of the act are sufficient to assure safety and effectiveness; into class II (special controls), if general controls, by themselves, are insufficient to provide reasonable assurance of safety and effectiveness, but there is sufficient information to establish special controls to provide such assurance; and into class III (premarket approval), if there is insufficient information to support classifying a device into class I or class II and the device is a life-sustaining or life- supporting device or is for a use which is of substantial importance in preventing impairment of human health, or presents a potential unreasonable risk of illness or injury. Most generic types of devices that were on the market before the date of the 1976 amendments (May 28, 1976) (generally referred to as preamendments devices) have been classified by FDA under the procedures set forth in section 513(c) and

(d)of the act through the issuance of classification regulations into one of these three regulatory classes. Devices introduced into interstate commerce for the first time on or after May 28, 1976 (generally referred to as postamendments devices) are classified through the premarket notification process under section 510(k) of the act (21 U.S.C. 360(k)). Section 510(k) of the act and the implementing regulations, 21 CFR part 807, require persons who intend to market a new device to submit a premarket notification report (510(k)) containing information that allows FDA to determine whether the new device is “substantially equivalent” within the meaning of section 513(i) of the act to a legally marketed device that does not require premarket approval. On November 21, 1997, the President signed into law FDAMA (Public Law 105-115). Section 206 of FDAMA, in part, added section 510(m) to the act. Section 510(m)(l) of the act requires FDA, within 60 days after enactment of FDAMA, to publish in the **Federal Register** a list of each type of class II device that does not require a report under section 510(k) of the act to provide reasonable assurance of safety and effectiveness. Section 510(m) of the act further provides that a 510(k) will no longer be required for these devices upon the date of publication of the list in the **Federal Register** . FDA published that list in the **Federal Register** of January 21, 1998 (63 FR 3142). Section 510(m)(2) of the act provides that, 1 day after date of publication of the list under section 510(m)(l), FDA may exempt a device on its own initiative or upon petition of an interested person, if FDA determines that a 510(k) is not necessary to provide reasonable assurance of the safety and effectiveness of the device. This section requires FDA to publish in the **Federal Register** a notice of intent to exempt a device, or of the petition, and to provide a 30-day comment period. Within 120 days of publication of this document, FDA must publish in the **Federal Register** its final determination regarding the exemption of the device that was the subject of the notice. If FDA fails to respond to a petition under this section within 180 days of receiving it, the petition shall be deemed granted. FDA classified the cranial orthosis into class II (special controls) effective August 31, 1998 (63 FR 40650, July 30, 1998). The classification regulation for cranial orthosis is at 21 CFR 882.5970. The cranial orthosis is identified as a device that is intended for medical purposes to apply pressure to prominent regions of an infant's cranium in order to improve cranial symmetry and/or shape in infants from 3 to 18 months of age, with moderate to severe nonsynostotic positional plagiocephaly, including infants with plagiocephalic-, brachycephalic-, and scaphocephalic-shaped heads. II. Criteria for Exemption There are a number of factors FDA may consider when determining whether a 510(k) is necessary to provide reasonable assurance of the safety and effectiveness of a class II device, including the factors discussed in the guidance entitled “Procedures for Class II Device Exemptions from Premarket Notification, Guidance for Industry and CDRH Staff” (available at *http://www.fda.gov/cdrh/modact/exemii.pdf* or by sending a fax request to 240-276-3151 to receive a hard copy). The factors outlined in the guidance included:

(1)The device does not have a significant history of false or misleading claims or risks associated with inherent characteristics of the device;

(2)characteristics of the device necessary for its safe and effective performance are well established;

(3)changes in the device that could affect safety and effectiveness will either

(a)be readily detectable by users by visual examination or other means such as routine testing, before causing harm, e.g., testing of a clinical laboratory reagent with positive or negative controls, or

(b)not materially increase the risk of injury, incorrect diagnosis, or ineffective treatment; and

(4)any changes to the device would not be likely to result in a change in the device's classification. FDA also considered that, even when exempting devices, these devices would still be subject to the limitations on exemptions. III. Petition FDA received a petition requesting an exemption from premarket notification for class II devices, 21 CFR 882.5970 Cranial orthosis, from Catherine Jeakle Hill, on behalf of the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS), and the AANS/CNS Section on Pediatrics. On October 24, 2006 (71 FR 62268), FDA published a notice announcing that this petition had been received and providing an opportunity for interested persons to submit comments on the petition by November 24, 2006. IV. Summary of Public Comments FDA received a total of 39 comments (42 individuals; 3 letters had 2 signatures) regarding this petition. We have summarized the comments as follows: A. Comments Supporting the Petition for Exemption FDA received 13 comments supporting an exemption from premarket notification for this type of device, including: Four comments stated that cranial orthoses have similar risks and technological considerations as those used for Class I exempt orthotics for use on other parts of the body. FDA disagrees. FDA has identified specific health risks inherent to the cranial orthosis indications and technological characteristics (63 FR 40650). Some of the literature referenced by the petitioner also identified the risks inherent to cranial orthoses, e.g., restriction of cranial growth. Eleven comments supported the petition stating that cranial orthoses are safe, and four comments stated that long term use is evidence of efficacy. One comment stated that the limitations to the exemption are sufficient for monitoring changes in intended use and technology. However, FDA believes that the petition failed to provide information, including potential special controls, to establish that premarket notification is not necessary to provide reasonable assurance of safety and effectiveness and to assure that health risks associated with inherent characteristics of the device and indications are addressed. Additionally, the petition failed to describe how changes in the device that could lead to device failures would either:

(1)Be readily detectable by users by visual examination or other means, such as routine testing, before causing harm; or

(2)not materially increase the risk of injury or ineffective treatment. In addition, the petitioner did not provide sufficient information to address the frequency, persistence, cause, or seriousness of the inherent risks of the device or to establish special controls to address the health risks associated with cranial orthoses. The petitioner did not specify whether a comprehensive search of the medical literature and other available, unpublished data was conducted to substantiate that the safety can be assured if cranial orthoses are exempted from the requirements of premarket notification. Some of the public comments identified literature regarding additional safety issues that had not been identified by the petitioner. One comment generally supported the petition, but stated that cranial orthoses indicated for posterior plagiocephaly should either have fabrication restrictions removed or the device should be pulled from the market until efficacy data is provided. FDA disagrees with this comment. Cranial orthoses are class II devices with special controls, including the requirement for premarket notification. This has assured reasonable safety and effectiveness for use with infants having posterior plagiocephaly. Eleven comments stated that current regulation requirements inflate cost. Additionally, four comments stated that current regulation requirements decrease accessibility. FDA has no comment because neither issue is a criterion for exemption of a class II device. B. Comments Opposing the Petition for Exemption FDA received 26 comments (29 individuals; 3 letters had 2 signatures) opposing an exemption from premarket notification for these devices, including: Twenty-four comments stated that exemption would fail to provide reasonable assurance of the safety and effectiveness of these devices. One comment states that special controls are required to ensure reasonable safety and effectiveness. FDA agrees that insufficient information is available in the petition for FDA to make a determination that premarket clearance is not necessary to provide reasonable assurance of safety and effectiveness. FDA also agrees that special controls are required in order to address the health risks associated with inherent characteristics and indications of this class II device, and FDA has established special controls for the device (63 FR 40650). In addition, we have previously determined that premarket notification review and clearance was necessary prior to introducing the device into commercial distribution. As discussed previously, the petitioner did not provide sufficient information, which might include special controls, to address the health risks associated with cranial orthoses and that would sufficiently address the factors FDA considers important in determining whether to grant an exemption of a class II device. One comment stated that there are no documented industry fabrication standards. FDA believes this comment refers to the lack of recognized voluntary standards. FDA agrees and notes that it has not recognized any consensus standards relevant to the fabrication of cranial orthoses that would suffice as special controls, which could sufficiently address the factors FDA considers important in determining whether to grant an exemption of a class II device. Nineteen comments stated that cranial orthoses should be regulated because they are indicated for a vulnerable population. One comment stated that the complexity of medical conditions that result in the need for treatment with these devices is just starting to be reported in the medical literature. FDA believes that the level of regulation needed for this condition in a vulnerable population is commensurate with class II, including special controls. The petition provided insufficient information for developing special controls that would provide reasonable assurance of safety and effectiveness, when used on infants with complex medical conditions, if this type of device was exempt from premarket notification. Four comments stated the petition has insufficient information for addressing the factors FDA considers important in determining whether to grant an exemption of a class II device from premarket notification, FDA agrees, as discussed earlier. One comment stated that exemption of cranial orthoses will allow unqualified individuals to treat these patients and lower the standard of care. FDA does not regulate the qualifications of healthcare practitioners. However, regardless of whether a class II device is exempt from premarket notification, FDA can require prescription use labeling for class II devices. Prescription use labeling is required for this type of device. Five comments stated that access has not been deterred by the Class II designation. Three comments stated that there is insufficient evidence that innovation has been deterred by the Class II designation. Five comments stated that price increases are due to the significant increase in the service-intensity of this therapy. FDA has no comment because none of these issues is a criterion for exemption of a class II device. V. Order After reviewing the petition and for the reasons explained previously, FDA has determined that the petition failed to provide information that premarket clearance is not necessary to provide reasonable assurance of safety and effectiveness. Therefore, FDA is issuing this order denying the petition requesting exemption for cranial orthosis from the premarket notification requirements. Dated: December 19, 2006. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E6-22072 Filed 12-22-06; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Neurological Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration

(FDA)is announcing an amendment to the notice of the meeting of the Neurological Devices Panel of the Medical Devices Advisory Committee. This meeting was originally announced in the **Federal Register** of December 6, 2006 (71 FR page 70780). The amendment is being made to reflect a change in the *Agenda* portion of the document, specifically to include the name of the sponsors and devices. There are no other changes. FOR FURTHER INFORMATION CONTACT: Janet L. Scudiero, Center for Devices and Radiological Health (HFZ-410), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240-276-3737, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512513. Please call the Information Line for up-to-date information on this meeting. SUPPLEMENTARY INFORMATION: In the **Federal Register** of December 6, 2006, FDA announced that a meeting of the Neurological Devices Panel of the Medical Devices Advisory Committee would be held on January 26, 2007. On page 70780, column 1, the *Agenda* portion of the document is amended to read as follows: *Agenda* : The committee will discuss and make recommendations on a premarket notification application, sponsored by Neuronetics, Inc., for the NeuroStar System for the treatment of major depressive disorder. The committee will also hear and discuss post approval study reports for two recently approved neurological device premarket approval applications: The VNS Therapy TM System, sponsored by Cyberonics, Inc., for treatment-resistant chronic or recurrent depression; and the Dural Sealant System, sponsored by Confluent Surgical, Inc., for use as an adjunct to sutured dural repair during cranial surgery to provide watertight closure. FDA intends to make background material available to the public no later than 1 business day before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting. Background material is available at *http://www.fda.gov/ohrms/dockets/ac/acmenu.htm* , click on the year 2007 and scroll down to the appropriate advisory committee link. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app.2) and 21 CFR part 14, relating to the advisory committees. Dated: December 18, 2006. Randall W. Lutter, Associate Commissioner for Policy and Planning. [FR Doc. E6-21995 Filed 12-22-06; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. SUMMARY: The Department of Health and Human Services

(HHS)notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the **Federal Register** on April 11, 1988 (53 FR 11970), and subsequently revised in the **Federal Register** on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644). A notice listing all currently certified laboratories is published in the **Federal Register** during the first week of each month. If any laboratory's certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory has withdrawn from the HHS National Laboratory Certification Program

(NLCP)during the past month, it will be listed at the end, and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at *http://workplace.samhsa.gov* and *http://www.drugfreeworkplace.gov.* FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh or Dr. Walter Vogl, Division of Workplace Programs, SAMHSA/CSAP, Room 2-1035, 1 Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. Subpart C of the Mandatory Guidelines, “Certification of Laboratories Engaged in Urine Drug Testing for Federal Agencies,” sets strict standards that laboratories must meet in order to conduct drug and specimen validity tests on urine specimens for Federal agencies. To become certified, an applicant laboratory must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories which claim to be in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A laboratory must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA) which attests that it has met minimum standards. In accordance with Subpart C of the Mandatory Guidelines dated April 13, 2004 (69 FR 19644), the following laboratories meet the minimum standards to conduct drug and specimen validity tests on urine specimens: ACL Laboratories, 8901 W. Lincoln Ave., West Allis, WI 53227. 414-328-7840/800-877-7016. (Formerly: Bayshore Clinical Laboratory). ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624. 585-429-2264. Advanced Toxicology Network, 3560 Air Center Cove, Suite 101, Memphis, TN 38118. 901-794-5770/888-290-1150. Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 37210. 615-255-2400. Baptist Medical Center—Toxicology Laboratory, 9601 I-630, Exit 7, Little Rock, AR 72205-7299. 501-202-2783. (Formerly: Forensic Toxicology Laboratory Baptist Medical Center). Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802. 800-445-6917. Diagnostic Services, Inc., dba DSI, 12700 Westlinks Drive, Fort Myers, FL 33913. 239-561-8200/800-735-5416. Doctors Laboratory, Inc., 2906 Julia Drive, Valdosta, GA 31602. 229-671-2281. DrugScan, Inc., P.O. Box 2969, 1119 Mearns Road, Warminster, PA 18974. 215-674-9310. Dynacare Kasper Medical Laboratories,* 10150-102 St., Suite 200, Edmonton, Alberta, Canada T5J 5E2. 780-451-3702/800-661-9876. ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655. 662-236-2609. Gamma-Dynacare Medical Laboratories,* A Division of the Gamma-Dynacare Laboratory Partnership, 245 Pall Mall Street, London, ONT, Canada N6A 1P4. 519-679-1630. General Medical Laboratories, 36 South Brooks St., Madison, WI 53715. 608-267-6225. Kroll Laboratory Specialists, Inc., 1111 Newton St., Gretna, LA 70053. 504-361-8989/800-433-3823. (Formerly: Laboratory Specialists, Inc.). Kroll Scientific Testing Laboratories, Inc., 450 Southlake Blvd., Richmond, VA 23236. 804-378-9130. (Formerly: Scientific Testing Laboratories, Inc.). Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040. 713-856-8288/800-800-2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869. 908-526-2400/800-437-4986. (Formerly: Roche Biomedical Laboratories, Inc.). Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709. 919-572-6900/800-833-3984. (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group). Laboratory Corporation of America Holdings, 10788 Roselle St., San Diego, CA 92121. 800-882-7272. (Formerly: Poisonlab, Inc.). Laboratory Corporation of America Holdings, 550 17th Ave., Suite 300, Seattle, WA 98122. 206-923-7020/800-898-0180. (Formerly: DrugProof, Division of Dynacare/Laboratory of Pathology, LLC; Laboratory of Pathology of Seattle, Inc.; DrugProof, Division of Laboratory of Pathology of Seattle, Inc.). Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671. 866-827-8042/800-233-6339. (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center). LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219. 913-888-3927/800-873-8845. (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.). Marshfield Laboratories, Forensic Toxicology Laboratory, 1000 North Oak Ave., Marshfield, WI 54449. 715-389-3734/800-331-3734. MAXXAM Analytics Inc.,* 6740 Campobello Road, Mississauga, ON, Canada L5N 2L8. 905-817-5700. (Formerly: NOVAMANN (Ontario), Inc.). MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112. 651-636-7466/800-832-3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232. 503-413-5295/800-950-5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417. 612-725-2088. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304. 661-322-4250/800-350-3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504. 888-747-3774. (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory). Oregon Medical Laboratories, 123 International Way, Springfield, OR 97477. 541-341-8092. Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311. 800-328-6942. (Formerly: Centinela Hospital Airport Toxicology Laboratory). Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204. 509-755-8991/800-541-7891x7. Physicians Reference Laboratory, 7800 West 110th St., Overland Park, KS 66210. 913-339-0372/800-821-3627. Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA 30340. 770-452-1590/800-729-6432. (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 4770 Regent Blvd., Irving, TX 75063. 800-824-6152. (Moved from the Dallas location on 03/31/01; Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 4230 South Burnham Ave., Suite 250, Las Vegas, NV 89119-5412. 702-733-7866/800-433-2750. (Formerly: Associated Pathologists Laboratories, Inc.). Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403. 610-631-4600/877-642-2216. (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories). Quest Diagnostics Incorporated, 506 E. State Pkwy., Schaumburg, IL 60173. 800-669-6995/847-885-2010. (Formerly: SmithKline Beecham Clinical Laboratories; International Toxicology Laboratories). Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405. 866-370-6699/818-989-2521. (Formerly: SmithKline Beecham Clinical Laboratories). Quest Diagnostics Incorporated, 2282 South Presidents Drive, Suite C, West Valley City, UT 84120. 801-606-6301/800-322-3361. (Formerly: Northwest Toxicology, a LabOne Company; LabOne, Inc., dba Northwest Toxicology; NWT Drug Testing, NorthWest Toxicology, Inc.; Northwest Drug Testing, a division of NWT Inc.). S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109. 505-727-6300/800-999-5227. South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South Bend, IN 46601. 574-234-4176 x276. Southwest Laboratories, 4645 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040. 602-438-8507/800-279-0027. Sparrow Health System, Toxicology Testing Center, St. Lawrence Campus, 1210 W. Saginaw, Lansing, MI 48915. 517-364-7400. (Formerly: St. Lawrence Hospital & Healthcare System). St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma City, OK 73101. 405-272-7052. Toxicology & Drug Monitoring Laboratory, University of Missouri Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO 65203. 573-882-1273. Toxicology Testing Service, Inc., 5426 N.W. 79th Ave., Miami, FL 33166. 305-593-2260. US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235. 301-677-7085. * The Standards Council of Canada

(SCC)voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation

(DOT)regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory ( **Federal Register** , July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the **Federal Register** on April 13, 2004 (69 FR 19644). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Elaine Parry, Acting Director, Office Program Services, SAMHSA. [FR Doc. E6-22049 Filed 12-22-06; 8:45 am] BILLING CODE 4162-20-P DEPARTMENT OF HOMELAND SECURITY Bureau of Customs and Border Protection Automated Commercial Environment (ACE): National Customs Automation Program Test of Automated Truck Manifest for Truck Carrier Accounts; Deployment Schedule AGENCY: Customs and Border Protection; Department of Homeland Security. ACTION: General notice. SUMMARY: The Bureau of Customs and Border Protection, in conjunction with the Department of Transportation, Federal Motor Carrier Safety Administration, is currently conducting a National Customs Automation Program

(NCAP)test concerning the transmission of automated truck manifest data. This document announces the next group, or cluster, of ports to be deployed for this test. DATES: The ports identified in this notice, in the State of Vermont, are expected to be fully deployed for testing by December 31, 2006. Comments concerning this notice and all aspects of the announced test may be submitted at any time during the test period. FOR FURTHER INFORMATION CONTACT: Mr. James Swanson via e-mail at *james.d.swanson@dhs.gov.* SUPPLEMENTARY INFORMATION: Background The National Customs Automation Program

(NCAP)test concerning the transmission of automated truck manifest data for truck carrier accounts was announced in a General Notice published in the **Federal Register** (69 FR 55167) on September 13, 2004. That notice stated that the test of the Automated Truck Manifest would be conducted in a phased approach, with primary deployment scheduled for no earlier than November 29, 2004. A series of **Federal Register** notices have announced the implementation of the test, beginning with a notice published on May 31, 2005 (70 FR 30964). As described in that document, the deployment sites for the test have been phased in as clusters. The ports identified belonging to the first cluster were announced in the May 31, 2005, notice. Additional clusters were announced in subsequent notices published in the **Federal Register** including: 70 FR 43892, published on July 29, 2005; 70 FR 60096, published on October 14, 2005; 71 FR 3875, published on January 24, 2006; 71 FR 23941, published on April 25, 2006; and 71 FR 42103, published on July 25, 2006. New Cluster Through this notice, CBP announces that the next cluster of ports to be brought up for purposes of deployment of the test, to be fully deployed by December 31, 2006, will be all ports in the State of Vermont. This deployment is for purposes of the test of the transmission of automated truck manifest data only; the Automated Commercial Environment

(ACE)Truck Manifest System is not yet the mandated transmission system for these ports. The ACE Truck Manifest System will become the mandatory transmission system in these ports only after publication in the **Federal Register** of 90 days notice, as explained by CBP in the **Federal Register** notice published on October 27, 2006 (71 FR 62922). Previous NCAP Notices Not Concerning Deployment Schedules On Monday, March 21, 2005, a General Notice was published in the **Federal Register** (70 FR 13514) announcing a modification to the NCAP test to clarify that all relevant data elements are required to be submitted in the automated truck manifest submission. That notice did not announce any change to the deployment schedule and is not affected by publication of this notice. All requirements and aspects of the test, as set forth in the September 13, 2004 notice, as modified by the March 21, 2005 notice, continue to be applicable. Dated: December 18, 2006. Jayson P. Ahern, Assistant Commissioner, Office of Field Operations. [FR Doc. E6-22036 Filed 12-22-06; 8:45 am] BILLING CODE 9111-14-P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service Receipt of Application of Endangered Species Recovery Permits AGENCY: Fish and Wildlife Service, Interior. ACTION: Notice of availability and receipt of applications. SUMMARY: We announce our receipt of applications to conduct certain activities pertaining to enhancement of survival of endangered species. DATES: Written comments on this request for a permit must be received by January 25, 2007. ADDRESSES: Written data or comments should be submitted to the Assistant Regional Director-Ecological Services, U.S. Fish and Wildlife Service, P.O. Box 25486, Denver Federal Center, Denver, Colorado 80225-0486; facsimile 303-236-0027. Documents and other information submitted with these applications are available for review, subject to the requirements of the Privacy Act [5 U.S.C. 552A] and Freedom of Information Act [5 U.S.C. 552], by any party who submits a request for a copy of such documents within 30 days of the date of publication of this notice to Kris Olsen, by mail or by telephone at 303-236-4256. All comments received from individuals become part of the official public record. SUPPLEMENTARY INFORMATION: The following applicants have requested issuance of enhancement of survival permits to conduct certain activities with endangered species pursuant to section 10(a)(1)(A) of the Endangered Species Act of 1973, as amended (16 U.S.C. 1531 *et seq.* ). *Applicant:* Toronto Zoo, Scarborough, Ontario, Canada, TE-051841, Hutchinson Zoo, Hutchinson, Kansas, TE-051824, and Elmwood Park Zoo, Norristown, Pennsylvania, TE-053485. The applicants request renewal of permits to possess captive-reared black-footed ferrets ( *Mustela nigripes* ) for public display and propagation in conjunction with recovery activities for the purpose of enhancing its survival and recovery. *Applicant:* Dakota Zoological Society, Inc., Bismarck, North Dakota, TE-051815. The applicant requests renewal of a permit to possess captive-reared black-footed ferrets ( *Mustela nigripes* ) and hatchery-reared pallid sturgeon ( *Scaphirhynchus albus* ) for public display and propagation in conjunction with recovery activities for the purpose of enhancing their survival and recovery. *Applicant:* Colorado Division of Wildlife, Native Aquatic Species Facility, Alamosa, Colorado, TE-047290. The applicant requests renewal of a permit to possess captive-reared bonytail ( *Gila elegans* ) and razorback sucker ( *Xyrauchen texanus* ) for public display and propagation in conjunction with recovery activities for the purpose of enhancing their survival and recovery. *Applicant:* Kirby Carroll, Buys and Associates, Littleton, Colorado, TE-056165. The applicant requests a renewed permit to take Mexican spotted owls ( *Strix occidentalis lucida* ) and Southwestern willow flycatchers ( *Empidonax traillii extimus* ) in conjunction with recovery activities throughout the species' range for the purpose of enhancing their survival and recovery. *Applicant:* U.S. Fish and Wildlife Service, Saratoga National Fish Hatchery, Saratoga, Wyoming, TE-052204. The applicant requests a renewed permit to take Wyoming toad ( *Bufo baxteri* ) in conjunction with recovery activities throughout the species' range for the purpose of enhancing its survival and recovery. Dated: November 14, 2006. James J. Slack, Deputy Regional Director, Denver, Colorado. [FR Doc. E6-22035 Filed 12-22-06; 8:45 am] BILLING CODE 4310-55-P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service Notice of Availability of the Draft Interim Visitor Services Plan for the Midway Atoll National Wildlife Refuge/Battle of Midway National Memorial/Midway Atoll Special Management Area AGENCY: Fish and Wildlife Service, Interior. ACTION: Notice of availability. SUMMARY: The Fish and Wildlife Service (Service) has completed a Draft Interim Visitor Services Plan

(VSP)and associated Environmental Assessment

(EA)for the Midway Atoll National Wildlife Refuge/Battle of Midway National Memorial/Midway Atoll Special Management Area (Refuge). The Draft VSP/EA is available for public review and comments. This remote Pacific island Refuge is a U.S. territory located in the Northwestern Hawaiian Islands, and part of the newly established Northwestern Hawaiian Islands Marine National Monument (Monument). The VSP is intended to guide visitor activities on the Refuge for an interim period of time until a broader Monument management plan is completed that meets the applicable requirements of a refuge comprehensive conservation plan. DATES: Written comments must be received (see ADDRESSES ) by midnight on February 6, 2007. ADDRESSES: Comments on the Draft VSP/EA should be submitted via electronic mail to *midway@fws.gov* . Please use “VSP” in the subject line. Alternatively, comments may be addressed to: Barbara Maxfield, Chief, Pacific Islands Division of External Affairs and Visitor Services, 300 Ala Moana Blvd., Room 5-231, Honolulu, HI 96850. You may view or obtain copies of the Draft VSP/EA as indicated under SUPPLEMENTARY INFORMATION . FOR MORE INFORMATION CONTACT: Barbara Maxfield, Chief, Pacific Islands Division of External Affairs and Visitor Services, phone number

(808)792-9531. SUPPLEMENTARY INFORMATION: The Draft VSP and EA were prepared pursuant to the National Wildlife Refuge System Administration Act of 1966, as amended by the National Wildlife Refuge System Improvement Act of 1997, and the National Environmental Policy Act of 1969, in consultation with the Secretary of Commerce through the National Oceanic and Atmospheric Administration (NOAA), and the State of Hawaii. Important elements of the Draft VSP/EA include: Allowing visitation only in limited numbers, and only from November through July, to ensure no adverse impacts to wildlife or their habitats occurs and to maintain a high quality visitor experience; and developing and maintaining a financially self-sustaining program and an associated table of proposed fees. The Draft VSP/EA will be available for viewing and downloading online at *http://www.fws.gov/midway* . Limited copies of the Draft VSP/EA may be obtained by writing to the U.S. Fish and Wildlife Service, Attn: Barbara Maxfield, Chief, Pacific Islands Division of External Affairs and Visitor Services, 300 Ala Moana Blvd., Room 5-231, Honolulu, HI, 96850. Copies of the Draft VSP/EA may be viewed at the Hawaiian and Pacific Islands National Wildlife Refuge Complex Office, Monday through Friday, during regular business hours from 7 a.m. to 4 p.m. The office is located in the Prince Jonah Kuhio Kalanianaole Federal Building at 300 Ala Moana Blvd., Room 5-231, Honolulu, HI. Background In 1996, the Service prepared a public use plan to guide visitor services on the Refuge. Since then, new laws and policy regarding wildlife-dependent recreation in the National Wildlife Refuge System have been promulgated, and a new visitor services plan is required to ensure recreational uses at the Refuge are compatible with the National Wildlife Refuge System mission and the purposes of the Refuge and the Battle of Midway National Memorial. In addition, all recreational activities must be compliant with the requirements of the newly designated Monument, which refers to the Refuge as a Special Management Area. The Draft VSP/EA is an interim plan to guide visitor activities on the Refuge until such time as the broader management plan is completed for the Monument that meets the applicable requirements of a refuge comprehensive conservation plan. The Monument's management plan will incorporate opportunities to participate in broader management and conservation activities, within the Northwestern Hawaiian Islands and throughout the main Hawaiian Islands, benefiting the Monument. The development of this Draft VSP/EA began prior to the establishment of the Monument to fulfill Service requirements necessary to allow a regularly scheduled visitor services program to resume at the Refuge. As such, the focus of activities under the Draft VSP/EA is limited to initial visitor services within the Midway Atoll Special Management Area only. Future planning for a Monument-wide visitor services program will be further developed to more fully realize the President's vision to create a visitor window to the Monument at the Refuge. In addition, future planning will explore opportunities for visitor use at Kure Atoll (under the jurisdiction of the State of Hawaii) and in the main Hawaiian Islands, using distance learning and remote educational opportunities. The Service will continue to work closely with its co-trustees of the Monument, NOAA and the State of Hawaii, when the final VSP is implemented, and in the development of the Monument's management plan. Longer-term strategies are included in this Draft VSP/EA, so the interested public may gain a vision of what the co-trustees envision at the Refuge. This Draft VSP/EA evaluates recreational activities at the Refuge, and describes the structure of the proposed visitor services program. It also outlines activities that honor and interpret the World War II history at Midway Atoll, in recognition of its status as the Battle of Midway National Memorial. It discusses operational limitations, biological constraints, and partnership opportunities beyond Midway Atoll. Since 1995, the Service has been strongly committed to welcoming visitors to the Refuge. This is the first and only remote island national wildlife refuge in the Pacific Ocean to provide the general public with an opportunity to learn about and experience these unique ecosystems. A regularly scheduled visitor program operated on the Refuge until early in 2002, when it ended after our cooperator left the atoll. Since then, visitors have arrived almost exclusively by the occasional cruise ship or sailboat, or for a Battle of Midway commemorative event. In the Draft VSP/EA, opportunities to expand the visitor program and allow more people to experience Midway's wildlife and historic treasury are proposed. Preliminary compatibility determinations are provided in the Draft VSP/EA that would allow the following wildlife-dependent recreational uses: Wildlife observation and photography, environmental education and interpretation, and participatory research. Hunting and fishing, two uses normally given priority on national wildlife refuges, will not take place on the Refuge. All animal species occurring on the Refuge are protected by law, or occur in numbers too low to provide hunting opportunities. Recreational fishing is precluded under the Presidential proclamation (Proclamation 8031) designating the Monument. Additional preliminary compatibility determinations allow for beach use activities such as swimming and volleyball, non-administrative airport operations, limited outdoor sports such as bicycling and jogging, and amateur radio use. Each preliminary compatibility determination includes stipulations necessary to ensure protection of the Refuge's natural and historic resources. Any additional activities that may be proposed within the Refuge would need to be evaluated through the compatibility determination process with formal public review. Activities that are determined to be compatible are authorized through the issuance of Monument permits, which fall within six permit types: Conservation and management, research, education, Native Hawaiian uses, special ocean uses, and recreation. Goals, objectives, and strategies for the visitor program are discussed in Chapter 4 of the Draft VSP/EA. The Service will encourage individual visitors as well as organized groups to visit the Refuge. Opportunities for teacher workshops in environmental education, college courses, and distance learning will be explored. Improvements to trails and installation of blinds will benefit wildlife observation and photography opportunities, as will snorkeling and guided kayaking tours. Onsite and offsite interpretation of Midway Atoll's historic and wildlife resources will be enhanced. In order to ensure a quality visitor experience using the limited infrastructure currently available, limiting the total number of overnight visitors that would be allowed on Midway Atoll at any one time to 30 people in 2007, and 50 people in 2008 and beyond, as long as the VSP is effective, is proposed. The number of visitors may exceed these limits for short periods of time (less than a day) for prearranged visits by ocean vessels or aircraft. In these cases, visitor activities are closely supervised and primarily consist of guided tours or participation in commemorative events. Annual goals for the number of overnight visitors are 100 people in 2007 and 500 people in 2008 and beyond. For the next 5 years (2007-2011), visitor programs would operate from November through July, which coincides with the albatross season on the Refuge. The months of August through October would be reserved primarily for planned construction and major maintenance activities. With no additional Service funding available to support a visitor program, visitation at the Refuge must be financially self-sustaining. Fees reflecting actual costs for transportation, lodging, food services, and visitor services staffing are included in this Draft VSP/EA. Additional permitting requirements also are discussed. For this interim period, the Service intends to operate the visitor program primarily with its own staffing and with help from Monument co-trustees and volunteers. Outside entities may be needed to provide assistance with marketing the program, and to establish a dive program at the Refuge. These options will be evaluated over the coming year. Public Comments Public comments are requested, considered, and incorporated throughout the planning process. After the review and comment period ends for the Draft VSP/EA, comments will be analyzed by the Service and addressed in revised planning documents. All comments received from individuals, including names and addresses, become part of the official public record and may be released. Requests for such comments will be handled in accordance with the Freedom of Information Act, the Council on Environmental Quality's NEPA regulations [40 CFR 1506.6(f)], and Service and Department of the Interior policies and procedures. Dated: December 6, 2006. David J. Wesley, Acting Regional Director, Region 1, Portland, Oregon. [FR Doc. E6-22112 Filed 12-22-06; 8:45 am] BILLING CODE 4310-55-P DEPARTMENT OF THE INTERIOR Geological Survey Inventory of Geological and Geophysical Collections at State Surveys AGENCY: U.S. Geological Survey. ACTION: Request for Public Comments on Proposed Information Collection Submitted to the Office of Management and Budget for Review Under the Paperwork Reduction Act. SUMMARY: The proposal to initiate the collection of information described below will be submitted to the Office of Management and Budget for approval under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35). Copies of the proposed collection of information and related forms may be obtained by contacting the Bureau's Clearance Officer at the phone number listed below. OMB has up to 60 days to approve the information collection, but may respond after 30 days; therefore public comments should be submitted to OMB within 30 days in order to assure maximum consideration. Comments and suggestions on the proposal should be made directly to the Desk Officer for the Interior Department, OMB-OIRA, via e-mail to *OIRA_DOCET@omb.eop.gov* or via facsimile to

(202)395-6566, and to the Bureau Clearance Officer, U.S. Geological Survey, 807 National Center, 12201 Sunrise Valley Drive, Reston, Virginia 20192. Specific public comments are requested as to: 1. Whether the collection of information is necessary for the proper performance of the functions of the Bureau, including whether the information will have practical utility; 2. The accuracy of the Bureau's estimate of the burden of the collection of information, including the validity of the methodology and assumptions use; 3. The quality, utility, and clarity of the information to be collected; and 4. How to minimize the burden of the collection of information on those who are to respond, including the use of the appropriate automated, electronic, mechanical, or other forms of information technology. *Title:* Inventory of Geological and Geophysical Collections at State Surveys. *OMB approval number:* 1028-. *Abstract:* Section 351 of the Energy Policy Act of 2005 directs the Secretary of the Interior, through the Director of the U.S. Geological Survey, “to carry out a National Geological and Geophysical data Preservation Program” (NGGDPP). The Implementation Plan for the National Geological and Geophysical Data Preservation Program submitted to Congress in August 2006 outlines the vision and purpose of the program and makes recommendations for implementation of the program. One of the action items in the FY 2007 implementation plan is to “begin interactions with State geological surveys and other DOI agencies that maintain geological and geophysical data and samples to address their preservation and data rescue needs.” As the first step in this process, the USGS is requesting that each state provide an assessment of their current collections resources and data preservation needs. This information will provide a snapshot of the diversity of scientific collections held, supported, or used by state geological surveys. The inventory covers geological and geophysical collections including:

(1)Physical collections such as cores, rocks, minerals, fossils, and liquid samples (such as oil).

(2)Digital collections (such as analyses and well logs) that are/were related to physical collections.

(3)Paper and other records (such as microfiche and tapes) that need to be converted to digital format (such as seismic lines and historical geological records). *Bureau Form Number:* None. *Frequency:* One time. *Description of Respondents:* State Geological Surveys. *Annual Responses:* 50. *Annual Burden in Hours:* 150. *Bureau Clearance Officer:* Fred Travnicek, 703-648-7231. FOR FURTHER INFORMATION CONTACT: Tamara Dickinson, U.S. Geological Survey, MS911 National Center, Reston, Virginia 20192,

(703)648-6633. P. Patrick Leahy, Associate Director for Geology, U.S. Geological Surveys. [FR Doc. 06-9843 Filed 12-22-06; 8:45 am]

Connectionstraces to 13

Traces to 13 documents

U.S. Code